Ilan Oren - 10 Sep 2025 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Reporting relationship: Director
Issuer ticker: ROIV
Reported as of: 10 Sep 2025
Net transaction value: -$28,132
SEC form: 4
Accepted by SEC: 12 Sep 2025, 21:00:23 UTC
Prior SEC filing: 21 Jul 2025
Next SEC filing: 22 Oct 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren

Key filing fact

Ilan Oren filed Form 4 for Roivant Sciences Ltd. (ROIV) on 12 Sep 2025.

Key facts

This page summarizes Ilan Oren's Form 4 filing for Roivant Sciences Ltd. (ROIV).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Sep 2025, 21:00.

Change

Previous filing in this sequence was filed on 21 Jul 2025.
Current net transaction value: -$28,132.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001643073 Primary reporting owner

Oren Ilan

Relationship: Director
Address: C/O ROIVANT SCIENCES LTD., 7TH FLOOR, 50 BROADWAY, LONDON, UNITED KINGDOM
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Ilan Oren
Signature date: 12 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ROIV transaction

Common Shares

Award

Transaction value: $0
Shares: +14,524
Change %: +14%
Price: $0.000000
Shares after: 119,205
Date: 10 Sep 2025
Ownership: Direct
Footnotes: F1

ROIV transaction

Common Shares

Other

Transaction value: $28,132
Shares: -2,043
Change %: -1.7%
Price: $13.77
Shares after: 117,162
Date: 10 Sep 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ROIV transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +33,726
Change %
Price: $0.000000
Shares after: 33,726
Date: 10 Sep 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 33,726
Exercise price: $13.77
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date.

Footnote F2

Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.

Footnote F3

Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2026, subject generally to the reporting person's continuous service through such date.